350 related articles for article (PubMed ID: 8940639)
1. Induction of humoral and cellular anti-idiotypic immunity by intradermal injection of naked DNA encoding a human variable region gene sequence of an immunoglobulin heavy chain in a B cell malignancy.
Abe A; Emi N; Taji H; Kasai M; Kohno A; Saito H
Gene Ther; 1996 Nov; 3(11):988-93. PubMed ID: 8940639
[TBL] [Abstract][Full Text] [Related]
2. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells.
Rinaldi M; Ria F; Parrella P; Signori E; Serra A; Ciafrè SA; Vespignani I; Lazzari M; Farace MG; Saglio G; Fazio VM
Cancer Res; 2001 Feb; 61(4):1555-62. PubMed ID: 11245465
[TBL] [Abstract][Full Text] [Related]
3. Generation of cytotoxic T lymphocytes specific for B-cell acute lymphoblastic leukemia family-shared peptides derived from immunoglobulin heavy chain framework region.
Liu Y; Zhu P; Hu YM
Chin Med J (Engl); 2007 Apr; 120(8):652-7. PubMed ID: 17517179
[TBL] [Abstract][Full Text] [Related]
4. Idiotype vaccination against murine B cell lymphoma. Humoral and cellular responses elicited by tumor-derived immunoglobulin M and its molecular subunits.
Campbell MJ; Carroll W; Kon S; Thielemans K; Rothbard JB; Levy S; Levy R
J Immunol; 1987 Oct; 139(8):2825-33. PubMed ID: 3498771
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin heavy chain variable region family usage is independent of tumor cell phenotype in human B lineage leukemias.
Deane M; Norton JD
Eur J Immunol; 1990 Oct; 20(10):2209-17. PubMed ID: 1700749
[TBL] [Abstract][Full Text] [Related]
6. Construction and characterization of DNA vaccines encoding the single-chain variable fragment of the anti-idiotype antibody 1A7 mimicking the tumor-associated antigen disialoganglioside GD2.
Zeytin HE; Tripathi PK; Bhattacharya-Chatterjee M; Foon KA; Chatterjee SK
Cancer Gene Ther; 2000 Nov; 7(11):1426-36. PubMed ID: 11129285
[TBL] [Abstract][Full Text] [Related]
7. Growth inhibition of a B cell leukemia: evidence implicating an anti-idiotype immune response for protective tumor immunity.
Ciavarra RP; Vitetta ES; Forman J
J Immunol; 1986 Aug; 137(4):1371-5. PubMed ID: 2426362
[TBL] [Abstract][Full Text] [Related]
8. T cells recognize the VH complementarity-determining region 3 of the idiotypic protein of B cell non-Hodgkin's lymphoma.
Wen YJ; Lim SH
Eur J Immunol; 1997 Apr; 27(4):1043-7. PubMed ID: 9130662
[TBL] [Abstract][Full Text] [Related]
9. Infrequent utilization of the immunoglobulin heavy chain variable region(s) identical or closely related to that of MOPC315 myeloma protein in the functional V region formation in B-precursor cell lines.
Sugiyama H; Minami Y; Komori T; Sakato N; Kishimoto S
Immunology; 1989 Dec; 68(4):453-7. PubMed ID: 2514136
[TBL] [Abstract][Full Text] [Related]
10. Anti-idiotypic DNA vaccines for lymphoma immunotherapy require the presence of both variable region genes for tumor protection.
Benvenuti F; Burrone OR; Efremov DG
Gene Ther; 2000 Apr; 7(7):605-11. PubMed ID: 10819576
[TBL] [Abstract][Full Text] [Related]
11. [Development of IgHV family specific nucleic acid vaccine against lymphoma by construction of fusion gene of immunoglobulin heavy chain variable region and cytokine].
Liu H; Zhu P; Lin NJ; Zhang Y; Bu DF; Wang YJ; Wang YQ; Yang Y
Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):48-53. PubMed ID: 14990159
[TBL] [Abstract][Full Text] [Related]
12. Absence of Ig V region gene somatic hypermutation in advanced Burkitt's lymphoma.
Carroll WL; Yu M; Link MP; Korsmeyer SJ
J Immunol; 1989 Jul; 143(2):692-8. PubMed ID: 2500485
[TBL] [Abstract][Full Text] [Related]
13. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.
Pewzner-Jung Y; Friedmann D; Sonoda E; Jung S; Rajewsky K; Eilat D
J Immunol; 1998 Nov; 161(9):4634-45. PubMed ID: 9794392
[TBL] [Abstract][Full Text] [Related]
14. [Specific humoral immune response against B-cell lymphoma elicited by mixed immunoglobulin fragments].
Lin N; Zhu P; Zhang X; Dong Y; Ren Y; Wang Y; Li W
Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(11):766-70. PubMed ID: 12126549
[TBL] [Abstract][Full Text] [Related]
15. Non-classical binding of a polyreactive α-type anti-idiotypic antibody to B cells.
Hernández T; de Acosta CM; López-Requena A; Moreno E; Alonso R; Fernández-Marrero Y; Pérez R
Mol Immunol; 2010; 48(1-3):98-108. PubMed ID: 20952071
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of a plasmid DNA vaccine encoding chimeric idiotype in patients with B-cell lymphoma.
Timmerman JM; Singh G; Hermanson G; Hobart P; Czerwinski DK; Taidi B; Rajapaksa R; Caspar CB; Van Beckhoven A; Levy R
Cancer Res; 2002 Oct; 62(20):5845-52. PubMed ID: 12384547
[TBL] [Abstract][Full Text] [Related]
17. An unusual clonotypic determinant on a cytotoxic T lymphocyte line is encoded by an immunoglobulin heavy chain variable region gene.
Ucker DS; Kurasawa Y; Tonegawa S
J Immunol; 1985 Dec; 135(6):4204-14. PubMed ID: 2415604
[TBL] [Abstract][Full Text] [Related]
18. [Proliferation of specific cytotoxic T lymphocytes induced by immunoglobulin heavy chain framework region-derived antigenic nonapeptides].
Liu Y; Zhu P; Hu YM
Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(2):97-102. PubMed ID: 14990121
[TBL] [Abstract][Full Text] [Related]
19. Maintenance of antigen-specific immunological memory through variable regions of heavy and light chains of anti-idiotypic antibody.
Vani J; Nayak R; Shaila MS
Immunology; 2007 Apr; 120(4):486-96. PubMed ID: 17229267
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning and sequence analysis of heavy- and light-chain variable region genes of anti-CD71 monoclonal antibody.
Wang ZY; Shen T; Zhang AH; Bi L; Jin YL; Sun KF; Yu MS; Shi LR
Di Yi Jun Yi Da Xue Xue Bao; 2002 May; 22(5):409-11. PubMed ID: 12390698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]